LEE SIKES RYLE: Open Payments
NPI 1215593025 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 66 payments from 16 companies in 2025. Trend: 2023 $740 · 2024 $1,244 · 2025 $1,205
Food & beverage: $1,113Education: $93
| Company | Payments | Amount |
|---|---|---|
| BioCryst US Sales Co., LLC | 28 | $264 |
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| GlaxoSmithKline, LLC. | 8 | $158 |
| Pharming Healthcare, Inc. | 4 | $98 |
| GENZYME CORPORATION | 3 | $87 |
| Regeneron Healthcare Solutions, Inc. | 2 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Optinose US, Inc. | 2 | $48 |
| Amgen Inc. | 1 | $34 |
Products named: ORLADEYO, DUPIXENT, NUCALA, RUCONEST, AIRSUPRA, TEZSPIRE, TRELEGY ELLIPTA, Xhance.
Industry payments across GA — which companies pay providers there.
